We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

News

News

Celldex Acquires Exclusive Rights to Immune-stimulatory Molecules from Amgen

FMS-like tyrosine kinase 3 ligand and CD40 ligand among assets to be utilized in cancer and anti-inflammatory immunotherapies.
News

Scientist Plans $245M Research Institute on Health Care

Dietrich Stephan, founding scientist of TGen, plans to plot research institute focused on personalized medicine in a 300,000-square-foot building in Northern Virginia.
News

UT Southwestern Researchers Reveal How the Brain Processes Important Information

Researchers shed light on how the neurotransmitter dopamine helps certain brain cells to become more flexible and changes brain-cell circuitry.
News

Lab21 and BreastHealth UK Form Partnership for Breast Health Management

The partners will offer UK women personalized health management and predictive genetic testing for breast cancer risk.
News

FASgen Announces Research and License Agreement with Centocor

Centocor to discover and develop novel small molecule inhibitors of the fatty acid biosynthesis pathway via selective inhibition of FAS for use in Oncology.
News

Vampires Go to Bat for Stroke Treatment

The stroke experts are hoping a blood thinner that mimics a chemical in vampire saliva will help save brain cells in stroke patients.
News

Brain Starvation as We Age Appears to Trigger Alzheimer’s

A slow, chronic starvation of the brain as we age appears to be one of the major triggers of a biochemical process that causes some forms of Alzheimer's disease.
News

Celera and Abbott Revise Strategic Alliance from Profit Sharing to Worldwide Distribution and Royalty Agreements

New agreements include distribution arrangement for certain Celera products and royalty-bearing arrangement for m2000™ sales.
News

In Vitro Diagnostics Industry Welcomes Pathology Report

The British In Vitro Diagnostics Association has welcomes the publication of the report of the second phase of Lord Carter’s Independent Review of Pathology Services.
News

Champions Biotechnology Partners to Establish Agreements for Preclinical Evaluation of Oncology Drugs

Champions Biotechnology’s Biomerk Tumorgrafts™ will be utilized by the Centocor for the preclinical evaluation of certain therapeutic agents.
Advertisement